Status:

UNKNOWN

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

Lead Sponsor:

Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)

Conditions:

Inflammatory Bowel Diseases

Eligibility:

All Genders

18+ years

Brief Summary

The COVID-19 pandemic has led to initial concerns for patients with Inflammatory Bowel Disease treated with immunosuppressive drugs, as they could be theoretically exposed to a higher risk of SARS-CoV...

Detailed Description

This is a 12-month, prospective, multicentre, case-control, observational study comparing effectiveness and safety of COVID-19 vaccine in patients with IBD treated with immunomodulatory drugs (cases) ...

Eligibility Criteria

Inclusion

  • Patients of either sex, without racial restriction, aged 18 years or older, willing to receive the COVID-19 vaccine
  • An established diagnosis of Crohn's disease or Ulcerative Colitis or unclassified colitis
  • Current treatment with conventional immunosuppressants (steroids, azathioprine, 6-mercaptopurine, methotrexate), biologics (infliximab, adalimumab, golimumab, vedolizumab, ustekinumab), or small molecule drugs (tofacitinib): will be included as cases
  • Currently off-therapy or treated with mesalamine only: will be included as controls
  • Capability to express a written informed consent for COVID-19 vaccination
  • Capability to express a written informed consent for the study

Exclusion

  • Primary immunodeficiencies and human immunodeficiency virus infection
  • Vaccination against SARS-CoV-2 already performed before enrolment
  • Contraindications to COVID-19 vaccine or intolerance to its components
  • Documented history of previous occurrence of COVID-19
  • Documented history of previous occurrence of asymptomatic SARS-CoV2 infection

Key Trial Info

Start Date :

March 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2022

Estimated Enrollment :

1380 Patients enrolled

Trial Details

Trial ID

NCT04769258

Start Date

March 1 2021

End Date

June 1 2022

Last Update

February 24 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.